Researchers concluded that dabrafenib and trametinib appeared active in the second-line adjuvant setting, “although more follow up is required to confirm.” ...

Designation will ease the gene-based breakthrough’s transition from laboratory to clinic with tax breaks and other investment ...

A paper published in the Journal of Clinical Oncology, titled "Comparative Analysis of Intracranial Response Assessment ...

Song Park, MD, University of Washington Medicine, advocates for more user-friendly technology to support equitable skin cancer care access.

Post-treatment evaluations showed that the immunotherapy eliminated 95% of pre-cancerous spots on subjects' faces.

Moderna/Merck partnership and its potential in personalised cancer therapies are good opportunities for long-term investors.

GEN uncovers seven biopharma-related trends based on interviews with experts and other industry stakeholders, as well as ...

A new study by investigators from Mass General Brigham uncovers how a novel immunotherapy prevents squamous cell carcinoma, with benefits lasting five years after treatment.

Researchers at Children's Hospital of Philadelphia (CHOP) and the University of Pennsylvania Perelman School of Medicine ...

More than 66,000 Americans will be diagnosed with pancreatic cancer this year. Learn more about the disease and how PanCAN can help.